EAACI Congress, London, 5th-9th June 2010
Nasaleze attended EAACI
Nasaleze attended the 29th Congress of the European Academy of Allergy and Clinical Immunology (EAACI). EAACI 2010 was the most important event of the year for everyone interested in allergy and allergic diseases. 8000 clinicians, researchers, academics and allied health professionals gathered in London to hear the latest developments in allergy, exchange ideas and update their clinical practice. EAACI 2010 was held at the new ExCeL exhibition and convention centre. 
Chairman
of the Nasaleze Scientific Advisory Board, Peter Josling, and Export Director,
Matt Duxbury, on the Nasaleze exhibition stand at EAACI.
Efficacy and safety of medical device Nasaval in prevention and treatment of persistent allergic rhinitis in adults and children
This paper describes the findings of an open non-comparative clinical study of efficacy and safety of an ultra-disperse cellulose preparation in prevention and treatment of persistent allergic rhinitis (AR).
Nasaval_Moscow_Zakharzhevskaya_English.pdf
|
